US equities |
MU $1,029.00 ▼-0.66% NVDA $229.28 ▼-0.52% SPCX $162.57 ▲+1.25% TSLA $382.70 ▲+2.05% AAPL $336.64 ▼-1.11% MSFT $535.07 ▲+2.38% AMZN $262.43 ▲+3.29% META $718.67 ▼-0.31%
FinancialContent

Latest News about IVBIY

Recent news which mentions IVBIY

FDA Rejects Lilly's Sintilimab/Chemo Combo Therapy In First-Line Lung Cancer Setting
Tickers IVBIY IVBXF LLY
Tags LLY IVBXF Penny Stocks
From Benzinga
FDA AdComm Votes Against Lilly's Lung Cancer Drug, Sintilimab
Tickers IVBIY IVBXF LLY
Tags Briefs Health Care lung cancer
From Benzinga
Innovent Biologics, UNION therapeutics Ink Licensing Pact For Inflammatory Dermatology Candidate
Tickers IVBIY IVBXF
Tags General IVBXF Biotech
From Benzinga
Innovent Biologics, Bolt Join Forces To Develop Anti-Cancer Candidates
Tickers BOLT IVBIY IVBXF
Tags IVBIY Market News News
From Benzinga
Innovent's Sintilimab/Chemo Regime Shows Overall Survival Benefit In Gastric Cancer
Tickers IVBIY IVBXF LLY
Tags Benzinga Biotech General
From Benzinga
Innovent - Eli Lilly's Sintilimab Combo Shows Sustained Survival Benefit In Lung Cancer Patients
Tickers IVBIY IVBXF LLY
Tags IVBIY Market News News
From Benzinga
Innovent Biologics - Incyte's Pemigatinib Application Under Review In China For Bile Duct Cancer
Tickers INCY IVBIY IVBXF
Tags General Biotech Benzinga
From Benzinga